Treatments with sodium selenate or doxycycline offset diabetes-induced perturbations of thioredoxin-1 levels and antioxidant capacity.
Diabetes is associated with increased oxidative stress and impaired antioxidant defenses. Thioredoxin-1 (TRX-1) is a cytosolic thiol antioxidant and redox-active protein which plays a vital role in the maintenance of reduced intracellular redox state. In this study, the authors examined whether 4-week treatments with sodium selenate and doxycycline--a metalloproteinase-2 inhibitor which also has antioxidant-like effects--offset perturbations in oxidative stress and antioxidant protection in rat liver and skeletal muscle in streptozotocin-induced diabetes (SID) model. Experimental diabetes decreased TRX-1 levels in skeletal muscle and liver. On the other hand, SID increased oxidative stress marker protein carbonyl levels and decreased oxygen radical absorbance capacity (ORAC), an indicator of antioxidant capacity, in liver. A 4-week treatment of sodium selenate to diabetic rats decreased blood glucose levels moderately, while doxycycline treatment caused a reduction in weight loss of diabetic rats. Both doxycycline and sodium selenate prevented diabetes-induced decrease of TRX-1 levels in skeletal muscle, whereas only doxyxycline was effectively preventing diabetes-induced decrease of TRX-1 in liver. Furthermore, both treatments prevented diabetes-induced altered levels of protein carbonyls and ORAC in liver, and restored free and total protein thiol levels in both skeletal muscle and liver. In conclusion, the data of this study provides further evidence that sodium selenate and doxycycline treatments may control oxidative stress and improve antioxidant defense in diabetes.
Institute of Biomedicine, Physiology, University of Eastern Finland, Kuopio, Finland.
Mustafa
M
Atalay
Ayca
A
Bilginoglu
Tarja
T
Kokkola
Niku
N
Oksala
Belma
B
Turan
D000818:Animals; D000975:Antioxidants / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D004318:Doxycycline / Q000494:pharmacology*; D008099:Liver / Q000378:metabolism; D008297:Male; D018482:Muscle, Skeletal / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D064586:Selenic Acid; D018036:Selenium Compounds / Q000494:pharmacology*; D013311:Streptozocin; D013879:Thioredoxins / Q000378:metabolism*
D000975:Antioxidants; D018036:Selenium Compounds; D013879:Thioredoxins; D013311:Streptozocin; D064586:Selenic Acid; D004318:Doxycycline
Biochem Pharmacol. 2007 Oct 1;74(7):969-80
17673183
Biol Trace Elem Res. 2002 Nov;89(2):165-75
12449240
Biol Trace Elem Res. 2005 Summer;105(1-3):135-50
16034159
Am Rev Respir Dis. 1989 Feb;139(2):370-2
2913886
Am J Physiol Heart Circ Physiol. 2005 Mar;288(3):H1417-24
15539426
Biochimie. 1995;77(12):919-24
8834772
Br J Pharmacol. 2008 Dec;155(8):1174-84
18806806
J Agric Food Chem. 2003 May 21;51(11):3273-9
12744654
J Appl Physiol (1985). 1999 Jun;86(6):1817-22
10368343
J Sports Sci Med. 2002 Mar 04;1(1):1-14
24672266
Int J Cardiol. 2005 Mar 18;99(2):225-31
15749180
Curr Opin Nephrol Hypertens. 2005 Mar;14(2):149-53
15687841
Dig Dis Sci. 2007 Aug;52(8):1897-905
17417732
Biochem Biophys Res Commun. 2005 Feb 4;327(1):163-73
15629445
Biochem Pharmacol. 2008 Jun 1;75(11):2092-9
18405881
J Appl Physiol (1985). 2009 Feb;106(2):461-7
19074570
Biol Trace Elem Res. 2005 Mar;103(3):207-16
15784954
Adv Dent Res. 1998 Nov;12(2):152-8
9972141
Ann N Y Acad Sci. 2000;899:191-208
10863540
Intern Med. 2005 Nov;44(11):1127-32
16357448
Horm Metab Res. 2002 Mar;34(3):160-4
11972307
Anticancer Res. 1997 Sep-Oct;17(5A):3377-80
9413175
Acta Physiol Scand. 1997 Oct;161(2):195-201
9366962
Biol Trace Elem Res. 2010 Jun;134(3):235-51
20306235
Circulation. 2005 Jul 26;112(4):544-52
16027249
Am J Physiol Cell Physiol. 2008 Oct;295(4):C849-68
18684987
Cardiovasc Res. 1996 Aug;32(2):351-61
8796123
Diabetes Res Clin Pract. 2000 Dec;50(3):213-23
11106836
Arch Immunol Ther Exp (Warsz). 2001;49(4):285-92
11726031
Biochem Pharmacol. 1999 Jan 15;57(2):187-93
9890567
Adv Dent Res. 1998 Nov;12(2):12-26
9972117
Chem Biol Interact. 2009 Jan 27;177(2):161-71
19010315
Circulation. 2000 Apr 18;101(15):1833-9
10769285
Semin Cancer Biol. 2006 Dec;16(6):420-6
17092741
Food Chem Toxicol. 2009 Oct;47(10):2484-9
19596040
Eur J Appl Physiol. 2005 Dec;95(5-6):550-6
16136323
Drug Metab Rev. 2000 Aug-Nov;32(3-4):307-26
11139131
Mol Cell Biochem. 2007 Oct;304(1-2):255-63
17530185
Arch Biochem Biophys. 2004 Jun 1;426(1):83-90
15130786
Birth Defects Res C Embryo Today. 2006 Mar;78(1):1-10
16622845
J Bone Miner Res. 1993 Oct;8(10):1247-53
8256662
Crit Rev Oral Biol Med. 1991;2(3):297-321
1654139
Open Dent J. 2008;2:5-12
19088876
Diabetes Metab. 2000 May;26(3):163-76
10880889